Ratio of observed to expected major adverse events (MAE) among patients undergoing congenital cardiac catheterization, risk-adjusted using the Catheterization for Congenital Heart Disease Adjustment for Risk Method II (CHARM II).
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.9 Care Setting1.20 Testing Data Sources
-
1.14 Numerator
Number of diagnostic and interventional cardiac catheterization cases resulting in a major adverse event at an institution performing at least 50 catheterization cases per year meeting the definition of a case type for case type risk categorization in patients with congenital heart disease.
-
1.15 Denominator
Number of diagnostic and interventional cardiac catheterization cases at an institution performing at least 50 cases per year meeting the definition of a case type for case type risk categorization in patients with congenital heart disease.
-
Exclusions
The following procedures are excluded: primary electrophysiology cases, ablation cases, pericardiocentesis only, thoracentesis only, and any procedure not performed in the catheterization laboratory, such as a case performed in an intensive care unit. In addition, cases without an assigned case type risk category are excluded.
-
Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Cardiovascular Spring Cycle 2020Initial EndorsementLast UpdatedRemoval Date
-
StewardSteward Organization EmailSteward Organization Copyright
N/A
-
-
-
Risk Adjustment
-
-
-
6.1.2 Current or Planned Use(s)6.1.3 Current Use(s)
-